Cat# : VAC-0344
| Catalog# | Product Name | Availability | Size | Price | Qty |
|---|---|---|---|---|---|
| VAC-0344 | Recombinant Gam-COVID-Vaccine | April 27, 2024 | 0.5ml | $1,998.00 |
|
| Add to Cart Online Order Request a Bulk Order | |||||
| Cat#: | VAC-0344 |
| Product Name: | Recombinant Gam-COVID-Vaccine |
| Description: | Gam-COVID-Vac was created by Gamaleya Research Institute of Epidemiology and MIcrobiology in Russia. The vaccine candidate is a heterologous COVID-19 vaccine containing two components, recombinant adenovirus type 26 (rAd26) vector and recombinant adenovirus type 5 (rAd5) vector which both carry the SARS-CoV-2 spike glycoprotein. The vaccine is offered in both a frozen (Gam-COVID-Vac) and freeze-dried formulation (lyophilizate; Gam-COVID-Vac Lyo). Phase 1/2 human trials with 76 participants evaluated the safety, tolerability, and immunogenicity of both frozen (Gam-COVID-Vac;NCT04436471) and freeze-dried (Gam-COVID-Vac Lyo;NCT04437875) vaccine candidates in June 2020, and were completed in early August 2020. Preliminary results suggested that all participants developed antibodies to the SARS-CoV-2 glycoproteins with a good safety profile in both trials. |
| Biologic Classification: | Vaccines Recombinant |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.
